Answers are grounded in this paper and cite their sources.
Advanced treatment of industrial wastewater is complicated by changes in the residual organic fraction after upstream treatment and by variation in production conditions. Compliance may be defined by bulk COD, individual contaminants, toxicity or reuse quality, which are distinct endpoints. This narrative review develops a common basis for selecting advanced oxidation, adsorption and membrane separation. It relates treatment mechanisms to process position and delivered dose, and evaluates resource use, secondary streams, maintenance and evidence quality. Laboratory experiments, pilot studies, design configurations and sustained full-scale operation are interpreted separately. Historical costs and design discharge limits are retained only within their reported boundaries. Fenton treatment is assessed together with peroxide consumption, acid and alkali demand, and iron-sludge management. For ozonation, applied, transferred and consumed ozone must be distinguished and transformation products and toxicity monitored. Electron-beam irradiation depends on absorbed-dose distribution, electrical efficiency and plant utilization. Adsorption and membranes provide complementary removal and separation functions, but sustained performance depends on breakthrough, regeneration and concentrate management. A selection flowchart and treatment-placement matrix relate these considerations to source control, biological treatment, oxidation and final separation. Future studies should report matched influent–effluent measurements, continuous operation and complete resource inventories for a defined endpoint and system boundary.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: